Intracellular dark endothelial spots (IDESs) on specular microscopy developed in 78/122 patients (63.9%) after Descemet stripping automated endothelial keratoplasty (DSAEK). Endothelial cell density ...
The phase 2 trial is enrolling Fuchs dystrophy patients who are scheduled to undergo Descemet Stripping Only (DSO), also known as Descemetorhexis Without Endothelial Keratoplasty (DWEK).
Objective: To evaluate the indications and outcomes of sutureless amniotic membrane transplant (AMT; ProKera) in the management of ocular surface disorders. Methods: Chart review of patients who ...